Advertisement

Sepsis pp 464-472 | Cite as

Arachidonic Acid Metabolism in Sepsis: What is the Role of Cyclooxygenase Inhibition?

  • G. R. Bernard
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 18)

Abstract

Since the first report of Northover and Subramanian [1] in 1962 on the use of aspirin to prevent death due to endotoxin shock in mongrel dogs, there has been a near-continuous stream of investigations the results of which support the potential for cyclooxygenase inhibition in sepsis syndrome. Many of these studies are survival studies, i.e., intervention with cyclooxygenase inhibitors is intended to determine effects on mortality. It is clear from these data that treatment with inhibitors of cyclooxygenase improves survival, though the biochemical and physiological mechanisms responsible for this beneficial effect have not been well understood until recently [2–8]. With the discovery of arachidonic acid and its metabolites, which include prostaglandins, thromboxanes, and leukotrienes, interpretations of the physiologic effects of cyclooxygenase inhibition have been attributed to key metabolites of arachidonic acid [5, 6]. In the past 15 years data have become available linking abnormalities of prostaglandin metabolism with airway mechanics abnormalities, pulmonary hypertension and the associated hypoxemia, cardiovascular collapse, and multiple organ system failure [6–14].

Keywords

Pulmonary Artery Pressure Arachidonic Acid Metabolism Cyclooxygenase Inhibition Sepsis Syndrome Endotoxin Shock 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Northover BJ, Subramanian G (1962) Analgesic-antipyretic drugs as antagonists of endotoxin shock in dogs. J Pathol Bacteriol 83:463–468PubMedCrossRefGoogle Scholar
  2. 2.
    Brigham KL, Meyrick B (1986) State of the art: endotoxin and lung injury. Am Rev Respir Dis 133:913–927PubMedGoogle Scholar
  3. 3.
    Fletcher JR, Ramwell PW (1977) Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol 61:175–181Google Scholar
  4. 4.
    Parratt JR, Sturgess RM (1975) E. coli endotoxin shock in the cat: treatment with indomethacin. Br J Pharmacol 53:485–488Google Scholar
  5. 5.
    Harris RH, Zmudka M, Maddox Y, Ramwell PW, Fletcher JR (1980) Relationships of TXB2 and 6-Keto PGF1a of the hemodynamic changes during baboon endotoxic shock. Adv Prostaglandin Thromboxane Leukotriene Res 7:843–849Google Scholar
  6. 6.
    Bowers RE, Ellis EF, Brigham KL, Oates JA (1979) Effects of prostaglandin cyclic endoperoxides on the lung circulation of sheep. J Clin Invest 63:131–137PubMedCrossRefGoogle Scholar
  7. 7.
    Hinshaw LB, Solomon LA, Erdos EG, Reins DA, Gunter BJ (1967) Effects of acetylsalicylic acid on the canine response to endotoxin. J Pharmacol Exp Ther 157:665–671PubMedGoogle Scholar
  8. 8.
    Snapper JR, Hutchison AA, Ogletree ML, Brigham KL (1983) Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep, J Clin Invest 72:63–76PubMedCrossRefGoogle Scholar
  9. 9.
    Mizus I, Michael J, Summer W, Gurtner G (1983) Acid aspiration induced pulmonary artery pressure rise is attenuated by hypoxia or ibuprofen. Crit Care Med 11:241 (abstract)Google Scholar
  10. 10.
    Perkowski SZ, Havill AM, Flynn JT, Gee MH (1983) Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation. Circ Res 53:574–583PubMedGoogle Scholar
  11. 11.
    Perlman MB, Johnson A, Malik AB (1987) Ibuprofen prevents thrombin-induced lung vascular injury: mechanism of effect. Am J Physiol 252:H605–H614PubMedGoogle Scholar
  12. 12.
    Kopolovic R, Thraikill KM, Martin DT, Ambrose T, Vento M, Carey LC, Cloutier CT (1984) Effects of ibuprofen on a porcine model of acute respiratory failure. J Surg Res 36:300–305PubMedCrossRefGoogle Scholar
  13. 13.
    Jacobs ER, Soulsby ME, Bone RC, Wilson FJ Jr, Hiller FC (1987) Ibuprofen in canine endotoxin shock. J Clin Invest 70:536–541CrossRefGoogle Scholar
  14. 14.
    Soulsby ME, Jacobs ER, Perlmutter BH, Bone RC (1984) Protection of myocardial function during endotoxin shock by ibuprofen. Prostaglandins Leukotrienes Med 13:295–305CrossRefGoogle Scholar
  15. 15.
    Bernard GR, Reines HD, Halushka PV et al (1991) Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome: effects of cyclooxygenase inhibition. Am Rev Respir Dis 144:1095–1101PubMedCrossRefGoogle Scholar
  16. 16.
    Wright PW, Bernard GR (1988) Effects of metaproterenol, atropine and ibuprofen on lung function during the late phase of endotoxemia in sheep. Am Rev Respir Dis 137:179Google Scholar
  17. 17.
    Wright PW, Bernard GR (1989) Mechanisms of the late hemodynamic and airway mechanics response to endotoxin in the awake sheep. Am Rev Respir Dis 140:672–678PubMedCrossRefGoogle Scholar
  18. 18.
    Rouzer CA, Scott WA, Hamill AL, Cohn ZA (1982) Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages. J Exp Med 155:720–733PubMedCrossRefGoogle Scholar
  19. 19.
    Brown KA, Collins AJ (1977) Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro. Ann Rheum Dis 36:239–243PubMedCrossRefGoogle Scholar
  20. 20.
    Kaplan HB, Edelson HS, Korchak HM, Given WP, Abramson S, Weissmann G (1984) Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol 33:371–378PubMedCrossRefGoogle Scholar
  21. 21.
    Bone RC, Fisher CJ, Clemmer TP et al (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658PubMedCrossRefGoogle Scholar
  22. 22.
    Luce JM, Montgomery AB, Marks JD et al (1988) Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 138:62–68PubMedCrossRefGoogle Scholar
  23. 23.
    The Veterans Administration Systemic Sepsis Cooperative Group (1987) The effects of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659–665CrossRefGoogle Scholar
  24. 24.
    Bernard GR, Luce JM, Sprung CL et al (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317:1565–1570PubMedCrossRefGoogle Scholar
  25. 25.
    Wright P, Ishihara Y, Bernard GR (1988) Effects of nitroprusside on lung mechanics and hemodynamics after endotoxemia in awake sheep. J Appl Physiol 64:2026–2032PubMedCrossRefGoogle Scholar
  26. 26.
    Gnidec AG, Sibbald W, Cheung H, Metz CA (1988) Ibuprofen ameliorates an increase in pulmonary microvascular fluid flux in a sheep model of surgically-induced peritonitis and permeability edema. J Appl Physiol 65:1024–1032PubMedGoogle Scholar
  27. 27.
    Rinaldo JE, Pennock B (1986) Effects of ibuprofen on endotoxin-induced alveolitis. Am J Med Sci 291:29–38PubMedCrossRefGoogle Scholar
  28. 28.
    Shinozawa Y, Hales C, Jung W, Burke J (1986) Ibuprofen prevents synthetic smokeinduced pulmonary edema. Am Rev Respir Dis 134:1145–1148PubMedGoogle Scholar
  29. 29.
    Sprague RS, Stephanson AH, Dahms TE, Asner NG, Lonigro AJ (1987) Effects of ibuprofen on the hypoxemia of established ethchlorvynol-induced unilateral acute lung injury in anesthetized dogs. Chest 92:1088–1093PubMedCrossRefGoogle Scholar
  30. 30.
    Garrett RC, Thomas HM III (1983) Meclofenamate uniformly decreases shunt fraction in dogs with lobar atelectasis. J Appl Physiol 540:284–289Google Scholar
  31. 31.
    Cook JA, Wise WC, Butler RR, Reines HD, Rambo W, Halushka PV (1984) The potential role of thromboxane and PGI2 in endotoxic and septic shock. Am J Emerg Med 2:28–37PubMedCrossRefGoogle Scholar
  32. 32.
    Passmore JC, Hartupee DA, Jackson BA (1987) Urinary and renal papillary solutes during cyclooxygenase inhibition with ibuprofen. J Lab Clin Med 110:807–812PubMedGoogle Scholar
  33. 33.
    Fink MP, Nelso R, Roethael R (1985) Low-dose dopamine preserves renal blood flow in endotoxin shocked dogs treated with ibuprofen. J Surg Res 38:582–591PubMedCrossRefGoogle Scholar
  34. 34.
    FitzGerald GA, Pedersen AK, Patrono C (1983) Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 67:1174–1177PubMedCrossRefGoogle Scholar
  35. 35.
    Hanly PJ, Roberts D, Dobson K, Light RB (1987) Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia. Lancet i: 351–354CrossRefGoogle Scholar
  36. 36.
    Wright PW, Marini JJ, Bernard GR (1988) Increased airway resistance contributes to impaired lung mechanics in the ARDS. Am Rev Respir Dis 137:137Google Scholar
  37. 37.
    Hasselström LJ, Eliasen K, Mogensen T, Andersen JB (1985) Lowering pulmonary artery pressure in a patient with severe acute respiratory failure. Intensive Care Med 11:48–50PubMedCrossRefGoogle Scholar
  38. 38.
    Michie HR, Manogue KR, Spriggs DR et al (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481–1486PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • G. R. Bernard

There are no affiliations available

Personalised recommendations